头颈癌198Au粒子近距离放疗3D计划系统剂量分布的影响
回顾性分析32例接受198Au粒子近距离放疗的头颈癌患者,其中25例单纯近距离放疗、7例联合新辅助外照射放疗。中位观察60个月,5年局部控制率82.9%;局部复发患者CTV的V85Gy趋向更低(p=0.07),发生骨暴露患者角化牙龈最大剂量显著更高(p=0.001)。结论认为198Au粒子剂量分布可预测局部控制和晚期不良事件。
要点
- 头颈癌198Au粒子近距离放疗后5年局部控制率为82.9%,中位观察60个月。
- 局部复发患者CTV的V85Gy趋向低于无复发患者(p=0.07)。
- 发生骨暴露患者角化牙龈最大剂量显著高于未发生骨暴露患者(p=0.001)。
核心结论
- 198Au粒子的剂量分布可预测局部控制和晚期不良事件。
研究设计与样本
- 回顾性分析32例接受198Au粒子治疗的头颈癌患者,其中25例单纯近距离放疗、7例联合新辅助外照射放疗。
主要发现
- 中位观察60个月,5年局部控制率为82.9%。
- 局部复发患者CTV的V85Gy趋向低于无局部复发患者(p=0.07)。
- 发生骨暴露患者角化牙龈最大剂量显著高于未发生骨暴露患者(p=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There has been no study in which the correlation between clinical results and dosimetry based on a 3D treatment planning system in patients with 198Au grains for head and neck cancer was evaluated. METHODS: Thirty-two patients who were treated with 198Au grains for head and neck cancer were reviewed. Twenty-five patients were treated with brachytherapy alone and seven patients were treated with a combination of brachytherapy and neoadjuvant external beam radiation therapy. RESULTS: With a median observation period of 60 months, the 5-year local control rate was 82.9%. V85Gy of CTV in patients with local recurrence tended to be lower than that in patients without local recurrence (p = 0.07). The maximum dose of the keratinized gingiva in patients in whom bone exposure occurred was significantly higher than that in patients in whom bone exposure did not occur (p = 0.001). CONCLUSIONS: Dose distribution with 198Au grains can predict local control and late adverse events.
引用
- Kishida K, Jingu K, Ito K, et al. Impact of dose distribution by a 3D planning system for brachytherapy with 198Au grains for head and neck cancer. Head Neck. 2024. PMID: 39011775. doi:10.1002/hed.27874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。